18
185680.KO Samsung KODEX Synth-US Biotech ETF
- KRW
No recent price
- Total assets
- 23.1B
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- +23.91%
- Holdings
- 1
- Since
- 2013
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does 185680.KO invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (101.0%)
- Largest sector: Healthcare (101.8%)
- Largest region: North America (101.0%)
Asset allocation
- US stocks 101.0%
- Non-US stocks 3.4%
Samsung KODEX Synth-US Biotech ETF performance
Sharpe ratio 1.12- This year
- +12.84%
- 1 year
- +23.91%
- 3 years
- +28.91%
- 5 years
- +5.17%
Volatility 28.9% over 1 year and 27.1% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
185680.KO price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Samsung KODEX Synth-US Biotech ETF top holdings
The holdings of Samsung KODEX Synth-US Biotech ETF are not available yet.
185680.KO sector exposure
- Healthcare101.8%
- Financial Services0.7%
Share of the stocks in the fund.
185680.KO regional exposure
- North America101.0%
- Europe Developed2.0%
- United Kingdom1.3%
- Asia Emerging0.0%
Share of the stocks in the fund.
Company size
Average market cap 10.5T- Big cap7.5%
- Medium cap14.8%
- Small cap49.0%
- Micro cap32.2%
Samsung KODEX Synth-US Biotech ETF fund profile
- Fund name
- Samsung KODEX Synth-US Biotech ETF
- Ticker
- 185680.KO
- Exchange
- Korea Stock Exchange
- Issuer
- -
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Inception date
- Oct 30, 2013
- Trading currency
- KRW
- Expense ratio
- -